Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2014; 20(42): 15852-15859
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15852
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15852
Restricted fluid (n = 89) | Standard fluid (n = 96) | P value | |
Patients with major surgical complications | 5 (5.6) | 13 (14.6) | 0.069 |
Total major surgical complications | 7 | 19 | |
Sepsis/shock | 2 | 5 | 0.29 |
Anastomotic bleeding | 1 | 3 | 0.62 |
Anastomotic leakage | 2 | 8 | 0.10 |
Peritonitis without leakage | 1 | 1 | 1.00 |
Patients with minor surgical complication | 22 (24.7) | 38 (39.6) | 0.03 |
Total minor surgical complications | 25 | 44 | |
Wound dehiscence, infection, haematoma | 13 | 15 | 0.85 |
Blood transfusion | 7 | 18 | 0.03 |
Patients with organ-specific complications | 21 (23.6) | 30 (31.3) | 0.24 |
Total organ-specific complications | 28 | 34 | |
Urinary tract infection | 5 | 10 | 0.23 |
Heart insufficiency | 8 | 1 | 0.02 |
Respiratory insufficiency | 1 | 1 | 1.00 |
Renal insufficiency | 3 | 0 | 0.11 |
Cognitive disorder | 3 | 7 | 0.34 |
Total postoperative complications | 60 | 97 | |
Total patients with complications | 36 (40.4) | 59 (61.5) | < 0.01 |
- Citation: Jie HY, Ye JL, Zhou HH, Li YX. Perioperative restricted fluid therapy preserves immunological function in patients with colorectal cancer. World J Gastroenterol 2014; 20(42): 15852-15859
- URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15852.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i42.15852